
PolarityTE PTE
Quarterly report 2023-Q1
added 05-12-2023
PolarityTE DIO Ratio 2011-2026 | PTE
Annual DIO Ratio PolarityTE
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 37.3 | 72.9 | 37.1 | 86.7 | - | - | - | 16.5 | 50.5 | 31.9 | 53.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 86.7 | 16.5 | 48.2 |
Quarterly DIO Ratio PolarityTE
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 5.47 | 22.2 | 26.5 | - | 59.6 | 91.3 | 100 | - | 35.6 | 38.6 | 34.6 | 80.5 | 46 | 185 | 15.3 K | - | - | - | - | - | - | - | 98.9 | 5.85 | - | 4.23 | 378 | 10.6 | 5.02 | 66.6 | 66 | 22.8 | 17.2 | 160 | 89.1 | 16.9 | 10.6 | 126 | 19.4 | 18.4 | 18 | 91.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.3 K | 4.23 | 540 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 330.34 | 3.6 % | $ 43.3 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
130 | $ 0.44 | -16.64 % | $ 5.04 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
119 | $ 24.98 | 1.17 % | $ 3.05 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Crinetics Pharmaceuticals
CRNX
|
343 | $ 37.7 | 1.26 % | $ 3.55 B | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.09 | -0.97 % | $ 437 M | ||
|
DBV Technologies S.A.
DBVT
|
332 | $ 20.36 | -3.32 % | $ 2.84 B | ||
|
Dyadic International
DYAI
|
161 | $ 0.87 | -2.8 % | $ 31.5 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B |